Key points are not available for this paper at this time.
Between 2010 and 2017, surgery rates among Scandinavian patients with IBD remained stable, with no clear changes in hospitalisation rates despite the increasing use of immunomodulators and biologics.
Zhao et al. (Thu,) studied this question.